[Therapy of Helicobacter pylori infection using Lactobacillus acidophilus]. 1998

Z Mrda, and M Zivanović, and J Rasić, and S Gajin, and L Somer, and S Trbojević, and J Majoros, and Z Petrović
Institut za interne bolesti, Medicinski Fakultet, Novi Sad.

BACKGROUND In vitro experiments with Lactobacillus acidophilus have revealed its inhibitory effect on Helicobacter pylori and its application in treatment of Helicobacter pylori positive gastritis was examined. METHODS 15 patients have undergone gastroscopy with biopsy and by histopathological examination. Helicobacter pylori positive gastritis was detected. During a two-month period these patients took acidophilus milk (3 x 250 ml a day) prepared according to a special protocol and which contained 4 x 10(9)-1 x 10(10) live cells of Lactobacillus acidophilus at the moment of preparation. Lactobacillus acidophilus strain NAS, gained from lyophilized preparation Bio-Nate (Natren Inc. USA) was used as a test organism. Control gastroscopy was performed 2 months later. RESULTS 14 patients have completed the examination. All of them were satisfied with the taste of acidophilus milk and could stand it well, whereas in 6 out of 14 Helicobacter pylori was eradicated. CONCLUSIONS Helicobacter pylori eradication therapy is recommended in all cases of Helicobacter pylori positive gastritis associated with peptic ulcer, as well as in absence of ulcer when subjective difficulties occur. Antibiotic therapy is often unsuccessful and most often associated with risks of significant adverse effects, being the consequence of intestinal microflora disorders. The aim of using Lactobacillus acidophilus in the therapy is to reduce risks of adverse effects. In our study, by using acidophilus milk only, without other therapy, eradication of Helicobacter pylori was achieved in 6 out of 14 patients. All patients could stand the therapy well and were satisfied with the taste of the preparation. The number of examinees was small in regard to making conclusions, but the results are encouraging and show that apart from established in vitro effect. Lactobacillus acidophilus has a potential in vivo effect.

UI MeSH Term Description Entries
D007779 Lactobacillus acidophilus A species of gram-positive, rod-shaped bacteria isolated from the intestinal tract of humans and animals, the human mouth, and vagina. This organism produces the fermented product, acidophilus milk. Lactobacillus amylovorus
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008892 Milk The off-white liquid secreted by the mammary glands of humans and other mammals. It contains proteins, sugar, lipids, vitamins, and minerals. Cow Milk,Cow's Milk,Milk, Cow,Milk, Cow's
D005260 Female Females
D005756 Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. Gastritides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae

Related Publications

Z Mrda, and M Zivanović, and J Rasić, and S Gajin, and L Somer, and S Trbojević, and J Majoros, and Z Petrović
January 2001, Current microbiology,
Z Mrda, and M Zivanović, and J Rasić, and S Gajin, and L Somer, and S Trbojević, and J Majoros, and Z Petrović
November 2000, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
Z Mrda, and M Zivanović, and J Rasić, and S Gajin, and L Somer, and S Trbojević, and J Majoros, and Z Petrović
April 2011, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Z Mrda, and M Zivanović, and J Rasić, and S Gajin, and L Somer, and S Trbojević, and J Majoros, and Z Petrović
January 1999, Digestion,
Z Mrda, and M Zivanović, and J Rasić, and S Gajin, and L Somer, and S Trbojević, and J Majoros, and Z Petrović
December 2000, Alimentary pharmacology & therapeutics,
Z Mrda, and M Zivanović, and J Rasić, and S Gajin, and L Somer, and S Trbojević, and J Majoros, and Z Petrović
January 2007, Medycyna doswiadczalna i mikrobiologia,
Z Mrda, and M Zivanović, and J Rasić, and S Gajin, and L Somer, and S Trbojević, and J Majoros, and Z Petrović
February 2010, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Z Mrda, and M Zivanović, and J Rasić, and S Gajin, and L Somer, and S Trbojević, and J Majoros, and Z Petrović
January 2020, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association,
Z Mrda, and M Zivanović, and J Rasić, and S Gajin, and L Somer, and S Trbojević, and J Majoros, and Z Petrović
May 2000, Praxis,
Z Mrda, and M Zivanović, and J Rasić, and S Gajin, and L Somer, and S Trbojević, and J Majoros, and Z Petrović
July 2015, MMW Fortschritte der Medizin,
Copied contents to your clipboard!